CRYSVITA: payments to doctors
Payments that named CRYSVITA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.6M
- Providers
- 15,560
- Transactions
- 29,993
- Average per transaction
- $119
The per-transaction average — $119 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 15,560 providers the average total is $230, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kyowa Kirin, Inc. | $2,268,948 | 63.5% |
| Ultragenyx Pharmaceutical Inc. | $1,257,627 | 35.2% |
| Kyowa Kirin Services Ltd | $48,586 | 1.4% |